Hirofumi Takei

Saitama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single-center, open-label study.

Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single-center, open-label study.

Journal: International journal of rheumatic diseases

Published: May 14, 2019

Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study.

Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study.

Journal: Rheumatology (Oxford, England)

Published: May 07, 2019

Efficacy and tolerability of six-week extended dosing interval with tocilizumab therapy in a prospective cohort as remission maintenance in patients with rheumatoid arthritis.

Efficacy and tolerability of six-week extended dosing interval with tocilizumab therapy in a prospective cohort as remission maintenance in patients with rheumatoid arthritis.

Journal: Modern rheumatology

Published: August 30, 2017

Current clinical evidence of tocilizumab for the treatment of ANCA-associated vasculitis: a prospective case series for microscopic polyangiitis in a combination with corticosteroids and literature review.

Current clinical evidence of tocilizumab for the treatment of ANCA-associated vasculitis: a prospective case series for microscopic polyangiitis in a combination with corticosteroids and literature review.

Journal: Clinical rheumatology

Published: June 27, 2017

Corticosteroid-free treatment of tocilizumab monotherapy for microscopic polyangiitis: a single-arm, single-center, clinical trial.

Corticosteroid-free treatment of tocilizumab monotherapy for microscopic polyangiitis: a single-arm, single-center, clinical trial.

Journal: Modern rheumatology

Published: March 03, 2016

Corticosteroid- and cyclophosphamide-free treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis using tocilizumab.

Corticosteroid- and cyclophosphamide-free treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis using tocilizumab.

Journal: Modern rheumatology

Published: March 05, 2015

Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.

Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.

Journal: Internal medicine (Tokyo, Japan)

Published: May 17, 2013

A case of multiple giant coronary aneurysms and abdominal aortic aneurysm coexisting with IgG4-related disease.

A case of multiple giant coronary aneurysms and abdominal aortic aneurysm coexisting with IgG4-related disease.

Journal: Internal medicine (Tokyo, Japan)

Published: April 17, 2012

Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis.

Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis.

Journal: Modern rheumatology

Published: December 02, 2011

Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review.

Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review.

Journal: Clinical rheumatology

Published: November 02, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026